BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22326864)

  • 1. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery.
    Reutlinger M; Schneider G
    J Mol Graph Model; 2012 Apr; 34():108-17. PubMed ID: 22326864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive combinatorial design of focused compound libraries.
    Schneider G; Schüller A
    Methods Mol Biol; 2009; 572():135-47. PubMed ID: 20694689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of self-organizing neural networks in virtual screening and diversity selection.
    Selzer P; Ertl P
    J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of molecular fingerprints.
    Owen JR; Nabney IT; Medina-Franco JL; López-Vallejo F
    J Chem Inf Model; 2011 Jul; 51(7):1552-63. PubMed ID: 21696145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular library design using multi-objective optimization methods.
    Nicolaou CA; Kannas CC
    Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping a screening file for maximal lead discovery efficiency and effectiveness: elimination of molecular redundancy.
    Bakken GA; Bell AS; Boehm M; Everett JR; Gonzales R; Hepworth D; Klug-McLeod JL; Lanfear J; Loesel J; Mathias J; Wood TP
    J Chem Inf Model; 2012 Nov; 52(11):2937-49. PubMed ID: 23062111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of combinatorial library methods in cancer research and drug discovery.
    Lam KS
    Anticancer Drug Des; 1997 Apr; 12(3):145-67. PubMed ID: 9154108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D; Fogel GB
    J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping algorithms for molecular similarity analysis and ligand-based virtual screening: design of DynaMAD and comparison with MAD and DMC.
    Eckert H; Vogt I; Bajorath J
    J Chem Inf Model; 2006; 46(4):1623-34. PubMed ID: 16859294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoinformatics and library design.
    Zhou JZ
    Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in visual representations of chemical space.
    Osolodkin DI; Radchenko EV; Orlov AA; Voronkov AE; Palyulin VA; Zefirov NS
    Expert Opin Drug Discov; 2015; 10(9):959-73. PubMed ID: 26094796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.